Skip to content

A study of the effect of the test food consumption on the postprandial glycemia

A study of the effect of the test food consumption on the postprandial glycemia - A study of the effect of the test food consumption on the postprandial glycemia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000053522
Enrollment
15
Registered
2024-02-09
Start date
2024-02-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Males and females aged 20 to 64 years old

Interventions

1. Single intake of the test food 1. 2. Washout period more than two days. 3. Single intake of the test food 2. 1. Single intake of the test food 2. 2. Washout period more than two days. 3. Sing

Sponsors

CPCC Company Limited
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Males and females aged 20 to 64 years old (2) Subjects whose fasting blood glucose levels are 125 mg/dL or under in the preliminary check. (3) Subjects whose HbA1c levels are 6.4% or under. (4) Subjects who can give informed consent to participate in this study, after being provided with an explanation of the protocol detail.

Exclusion criteria

Exclusion criteria: (1) Subjects who are having Food for Specified Health Uses (FOSHU), Foods with functional claims and/or health food, including supplements, (including suppression of blood glucose level elevation, etc.) which might affect this study, three times or more a week. (2)Subjects who are taking medications (e.g., diabetes medications) that may affect this study. (3) Subjects who are participating, participated within the last four weeks before this study, or are planning to participate another clinical study of medication or health food. (4) Subjects who have extremely disheveled dietary habits. (5) Subjects who have disheveled lifestyle (e.g., shift workers and night workers). (6) Heavy drinkers (7) Subjects with abnormal thyroid function in the preliminary check. (8) Subjects who have been diagnosed as anemia or have subjective symptoms of anemia. (9) Subjects who have past and present medical history of serious diseases of heart, liver, kidney, digestive organs, and/or thyroid gland, etc. (10) Pregnant women, lactating women, or women who want to get pregnant during this study. (11) Subjects who are allergic to drugs or food. (12) Subjects who have donated over 200 mL of whole blood and/or blood components within the last one month prior to this study. (13) Male subjects who have donated over 400 mL of whole blood within the last three months prior to this study. (14) Female subjects who have donated over 400 mL of whole blood within the last four months prior to this study. (15) Male subjects whose total volume of the blood drawn within the last 12 months and this study exceed 1200 mL (16) Female subjects whose total volume of the blood drawn within the last 12 months and this study exceed 1200 mL (17) Subjects who have been determined ineligible by principal investigator or sub-investigator.

Design outcomes

Primary

MeasureTime frame
glucose

Secondary

MeasureTime frame
Insulin Glucagon GLP-1 GIP

Countries

Japan

Contacts

Public ContactMidori Natsume

Meiji Co., Ltd. Food Microbiology and Function Research Laboratories, R&D Division

midori.natsume@meiji.com042-632-5847

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026